International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

van Huizen A. M., Menting S. P., Gyulai R., Iversen L., van der Kraaij G. E., Middelkamp-Hup M. A., ...Daha Fazla

JAMA DERMATOLOGY, cilt.158, sa.5, ss.561-572, 2022 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 158 Sayı: 5
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1001/jamadermatol.2022.0434
  • Dergi Adı: JAMA DERMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, MEDLINE, DIALNET
  • Sayfa Sayıları: ss.561-572
  • Akdeniz Üniversitesi Adresli: Hayır

Özet

IMPORTANCE A clear dosing regimen for methotrexate in psoriasis is lacking, and this might lead to a suboptimal treatment. Because methotrexate is affordable and globally available, a uniform dosing regimen could potentially optimize the treatment of patients with psoriasis worldwide.